Could this be the answer for people with quadriplegia?

Neuralink founder Elon Musk recently announced on X, a social media company also owned by Musk, that the first patient to receive the company’s implanted brain chip “is recovering well.”

The company received Food and Drug Administration (FDA) approval for trials last May. The clinical trial known as PRIME — Precise Robotically Implanted Brain-Computer Interface—sought individuals ages 22 and above, living with quadriplegia due to a spinal cord injury or amyotrophic lateral sclerosis (ALS), the disease that robs people of the ability to control their bodies.

Read more about the procedure here.